Malin Hultcrantz: Colesevelam for treatment of lenalidomide associated diarrhea

Elias K. Mai, Board Certified Specialist in Internal Medicine, Hematology and Oncology at University Hospital Heidelberg, shared a post by Malin Hultcrantz, Associate Attending Physician, Assistant Professor at MSK Cancer Center, on X, adding:

“Practice informing study on supportive care in MM by Malin Hultcrantz and colleagues. Congratulations!

I use it in my daily practice for many years now, but back-up from trials like this is essential!”

Quoting Malin Hultcrantz’s post:

“Colesevelam is highly effective and safe for treatment of lenalidomide associated diarrhea:

– Phase 2 trial, 25 patients
– 88% improved diarrhea
– 68% complete resolution
– No effect on lenalidomide PK”

Source: Elias K. Mai/X and Malin Hultcrantz/X